Agios Pharmaceuticals | AGIO - Interest Income


Agios Pharmaceuticals reported $14.51M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Agios Pharmaceuticals USD 14.51M 1.57M Jun/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Arrowhead Research USD 9.05M 1.97M Sep/2025
Astellas Pharma JPY 4.12B 2.94B Mar/2024
AstraZeneca USD 68M 16M Jun/2025
Bayer EUR 130M 38M Sep/2025
Biogen USD 32.3M 8.4M Jun/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Daiichi Sankyo JPY 9.96B 230M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 73M 21M Jun/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Incyte USD 25.14M 2.21M Jun/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Merck USD 96M 27M Sep/2025
Moderna USD 81M 9M Jun/2025
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025